25Jun
Blog: SEC Amendments to Financial Disclosure Requirements Provide a Welcome Reprieve for Carve-Out Transactions
As previously reported in this Cooley PubCo post, on May 21, the SEC adopted final amendments to the financial disclosure requirements for the acquisition and disposition of businesses. One change relating to the use of abbreviated financial statements stands out as a welcome reform for public or pre-public biopharma and life sciences companies....
By:
Cooley LLP
Related
The sixth of a six-part series examining six specific and evolving rights plan provisions. As discu...
Read More >
In UDOT v. Target Corp. et al., 2020 UT 10, the Utah Supreme Court recently clarified the standard b...
Read More >
NEW JERSEY - Governor Murphy issued the Statewide “Stay at Home” Order, Executive Order No. 107 (E...
Read More >
With 169 special purpose acquisition company (SPAC) initial public offerings (IPOs) and 102 SPAC mer...
Read More >
The global presence of the People’s Republic of China (China or PRC) in the construction space is u...
Read More >
On July 17, 2019, the Internal Revenue Service (the “IRS”) released Notice 2019-45 which expands t...
Read More >